340B Report (February 24, 2024) - The drugmaker vendor 340B ESP’s recent requests for additional claims data from some 340B hospitals has raised concerns from 340B providers that the vendor is going beyond the scope of what it is legally...
340B Report (February 24, 2024) – The drugmaker vendor 340B ESP’s recent requests for additional claims data from some 340B hospitals has raised concerns from 340B providers that the vendor is going beyond the scope of what it is legally permissible to collect.
An email obtained by 340B Report from 340B ESP to a 340B hospital asked the provider to help determine “how best to collect claims data for 340B utilization that occurs within an outpatient setting – as opposed to claims related to retail dispenses…
More Articles
Digital sales, software, inventory, and multistate operations can expand a company’s state tax footprint. Understanding where obligations arise can help businesses manage exposure and plan...
In cannabis transactions, key details may carry over after the deal closes. Understand how prior tax filings, Section 280E, and deal structure can shape a...
From the monthly close to internal controls and board reporting, strong financial management depends on a series of interconnected practices. AAFCPAs’ David Kelleher and Lauren...
